Tag: Blurred vision
Can Cara Therapeutics buck the trend?
Cara Therapeutics (NASDAQ: CARA) recently posted its first quarter, 2019 results. The company reported a net loss of $22.0 million, or $0.56 per basic...
Emerging Therapeutics in Preeclampsia Management
Preeclampsia is a pregnancy related complication that affects over 5% to 8% of pregnancies or about 3,00,000 women in the US alone. An estimated...
We are looking for talented interns to learn and help investors find valuable companies.